Works matching IS 09733930 AND DT 2022 AND VI 42 AND IP 1


Results: 21
    1
    2

    RSSDI consensus recommendations for dyslipidemia management in diabetes mellitus.

    Published in:
    International Journal of Diabetes in Developing Countries, 2022, v. 42, n. 1, p. 3, doi. 10.1007/s13410-022-01063-6
    By:
    • Saboo, Banshi;
    • Agarwal, Sanjay;
    • Makkar, Brij Mohan;
    • Chawla, Rajeev;
    • Ghosh, Sujoy;
    • Viswanathan, Vijay;
    • Gupta, Sunil;
    • Kumar, Ch. Vasanth;
    • Maheshwari, Anuj;
    • Sreenivasamurthy, L.;
    • Sahay, Rakesh Kumar;
    • Reddy, Sanjay;
    • Jaggi, Shalini;
    • Sharma, Jugal Kishor;
    • Panikar, Vijay;
    • Moses, Anand;
    • Bhattacharjee, Bikash;
    • Jethwani, Pratap;
    • Bhandari, Sudhir;
    • Sawhney, J. P. S.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Add-on therapy with dapagliflozin in routine outpatient care of type 2 diabetes patients from Turkey: a retrospective cohort study on HbA1c, body weight, and blood pressure outcomes.

    Published in:
    International Journal of Diabetes in Developing Countries, 2022, v. 42, n. 1, p. 147, doi. 10.1007/s13410-021-00954-4
    By:
    • Ertugrul, Derun Taner;
    • Kan, Erdal;
    • Tura, Cigdem Bahadir;
    • Tugtekin, Haci Bayram;
    • Ayakta, Hayati;
    • Celebioglu, Mehmet;
    • Yılmaz, Ceren;
    • Utebay, Onur;
    • Yetkin, Ilhan;
    • The DAPATURK Study Group;
    • Gurkan, Eren;
    • Sezer, Kerem;
    • Gen, Ramazan;
    • Ozcaylak, Suleyman;
    • Okuturlar, Yildiz;
    • Coskun, Mehmet;
    • Giynas, Nilgun Govec;
    • Aysal, Harun;
    • Erdem, Ayca Serap;
    • Aydemir, Mustafa
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21